VANGUARD GROUP INC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$802,187,959
+12.2%
5,044,890
-0.2%
0.02%
+17.6%
Q2 2023$715,278,061
-16.4%
5,056,398
-0.5%
0.02%
-22.7%
Q1 2023$855,591,883
-2.9%
5,081,919
-2.4%
0.02%
-8.3%
Q4 2022$881,284,793
-8.2%
5,205,155
+1.5%
0.02%
-14.3%
Q3 2022$959,665,000
+15.8%
5,128,884
+0.5%
0.03%
+21.7%
Q2 2022$828,871,000
-9.9%
5,103,886
+4.3%
0.02%
+4.5%
Q1 2022$920,062,000
-29.3%
4,891,604
-0.4%
0.02%
-26.7%
Q4 2021$1,301,098,000
-7.6%
4,912,769
+0.9%
0.03%
-14.3%
Q3 2021$1,407,745,000
+44.1%
4,871,260
-0.5%
0.04%
+45.8%
Q2 2021$976,947,000
+3.4%
4,894,031
+0.7%
0.02%
-7.7%
Q1 2021$945,227,000
+11.8%
4,862,028
+10.2%
0.03%
+4.0%
Q4 2020$845,231,000
+34.7%
4,410,742
+3.7%
0.02%
+19.0%
Q3 2020$627,270,000
+15.7%
4,251,530
-3.1%
0.02%
+10.5%
Q2 2020$542,122,000
+23.4%
4,385,752
-3.6%
0.02%0.0%
Q1 2020$439,285,000
+6.3%
4,550,285
+1.8%
0.02%
+35.7%
Q4 2019$413,396,000
+23.2%
4,469,147
+2.2%
0.01%
+16.7%
Q3 2019$335,415,000
-11.7%
4,373,651
-1.1%
0.01%
-14.3%
Q2 2019$379,940,000
+56.3%
4,420,485
+7.4%
0.01%
+40.0%
Q1 2019$243,132,000
+14.4%
4,115,290
+2.1%
0.01%0.0%
Q4 2018$212,578,000
-2.3%
4,030,671
+2.7%
0.01%
+11.1%
Q3 2018$217,577,000
+51.4%
3,923,135
+28.4%
0.01%
+50.0%
Q2 2018$143,709,000
+34.2%
3,055,042
+3.3%
0.01%
+20.0%
Q1 2018$107,046,000
+4.4%
2,958,699
+4.7%
0.01%
+25.0%
Q4 2017$102,564,000
-5.6%
2,826,995
-0.3%
0.00%
-20.0%
Q3 2017$108,640,000
+32.1%
2,835,082
+42.9%
0.01%
+25.0%
Q2 2017$82,233,000
+29.1%
1,984,393
+9.7%
0.00%
+33.3%
Q1 2017$63,683,000
+22.2%
1,809,202
+7.0%
0.00%0.0%
Q4 2016$52,105,000
+5.4%
1,690,617
+3.2%
0.00%0.0%
Q3 2016$49,445,000
+15.4%
1,637,769
+4.6%
0.00%0.0%
Q2 2016$42,838,000
+9.1%
1,565,708
+7.0%
0.00%0.0%
Q1 2016$39,255,000
-0.9%
1,463,678
+4.5%
0.00%0.0%
Q4 2015$39,629,000
+5.8%
1,400,777
+4.2%
0.00%
+200.0%
Q3 2015$37,455,000
-28.3%
1,344,881
+6.2%
0.00%
-75.0%
Q2 2015$52,268,000
+38.0%
1,266,503
+1.6%
0.00%
+33.3%
Q1 2015$37,862,000
+61.1%
1,247,083
+5.1%
0.00%
+50.0%
Q4 2014$23,501,000
+2.9%
1,186,986
+3.5%
0.00%0.0%
Q3 2014$22,839,000
-10.0%
1,147,106
+3.0%
0.00%0.0%
Q2 2014$25,379,000
+121.0%
1,113,605
+24.7%
0.00%
+100.0%
Q1 2014$11,484,000
-0.2%
893,053
+5.8%
0.00%0.0%
Q4 2013$11,510,000
+29.6%
843,868
+5.3%
0.00%0.0%
Q3 2013$8,884,000
+34.8%
801,076
+0.2%
0.00%0.0%
Q2 2013$6,590,000799,8340.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders